Carcinoid syndrome
European Journal of Surgical Oncology (EJSO), ISSN: 0748-7983, Vol: 34, Issue: 3, Page: 289-296
2008
- 27Citations
- 36Captures
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations27
- Citation Indexes27
- 27
- CrossRef22
- Captures36
- Readers36
- 36
Review Description
As clinical awareness increases, carcinoid is becoming increasingly identified, often at an earlier stage in the course of the disease. However, many patients remain undiagnosed until well into the late stages of the illness, at the time when their carcinoid syndrome becomes apparent. This review examines contemporary methods of detecting and assessing advanced carcinoid disease, and then continues to discuss strategies (both potentially curative and palliative) to control symptoms, and both prolong and improve quality of life for these patients.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S0748798307005185; http://dx.doi.org/10.1016/j.ejso.2007.07.202; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=39849090661&origin=inward; http://www.ncbi.nlm.nih.gov/pubmed/18068329; https://linkinghub.elsevier.com/retrieve/pii/S0748798307005185; https://dx.doi.org/10.1016/j.ejso.2007.07.202
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know